Literature DB >> 29270751

Cardiac myeloperoxidase activity is elevated in hypertensive pregnant rats.

Ming-Lin Zhu1, Jin-Ping Zhao2, Ning Cui3, Victor H Gonçalves-Rizzi4, Jose S Possomato-Vieira4, Regina A Nascimento4, Carlos A Dias-Junior5.   

Abstract

Myeloperoxidase (MPO) is released from activated neutrophils. The inflammation in preeclampsia was found to be associated with endothelial dysfunction. We hypothesized that cardiac and circulating MPO levels are elevated in hypertensive pregnancy. Systolic and diastolic blood pressure and heart rate were measured on pregnancy days 14, 16, 18 and 20 in normal pregnant and hypertensive pregnant rats. Left and right ventricle weights, the number of viable fetuses, litter size, fetal and placenta weights were recorded on gestational day 21. Circulating and cardiac MPO activities, soluble fms-like tyrosine kinase-1 (sFlt-1) and vascular endothelial growth factor (VEGF) and nitric oxide (NO) were detected. The results showed increases in cardiac (left, but not right ventricle) and circulating MPO activities, and concomitantly lower number of viable fetuses, litter size, and fetal and placenta weights, and decreases in NO in hypertensive pregnant rats. Also, the increases in circulating sFlt-1 and VEGF were found in hypertensive pregnant group. In conclusion, maternal and fetal detrimental changes along with increases in circulating sFlt-1 and VEGF in hypertensive pregnancy may be associated with increases in cardiac and circulating MPO activities, confirming the causative role of inflammatory response in preeclampsia.

Entities:  

Keywords:  hypertensive pregnancy; myeloperoxidase; preeclampsia; rats

Mesh:

Substances:

Year:  2017        PMID: 29270751     DOI: 10.1007/s11596-017-1825-6

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  36 in total

1.  17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model.

Authors:  Lorena M Amaral; Denise C Cornelius; Ashlyn Harmon; Janae Moseley; James N Martin; Babbette LaMarca
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration.

Authors:  S Baldus; J P Eiserich; A Mani; L Castro; M Figueroa; P Chumley; W Ma; A Tousson; C R White; D C Bullard; M L Brennan; A J Lusis; K P Moore; B A Freeman
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

3.  Morphologic changes of the uteroplacental unit in preeclampsia-like syndrome in rats.

Authors:  Andreas J Mayr; Wolfgang Lederer; Hannes J Wolf; Martin Dünser; Kristian Pfaller; Manfred G Mörtl
Journal:  Hypertens Pregnancy       Date:  2005       Impact factor: 2.108

4.  Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.

Authors:  Joseph A Vita; Marie-Luise Brennan; Noyan Gokce; Shirley A Mann; Marlene Goormastic; Mehdi H Shishehbor; Marc S Penn; John F Keaney; Stanley L Hazen
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

5.  Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia.

Authors:  Valeria C Sandrim; Ana C T Palei; Ingrid F Metzger; Valeria A Gomes; Ricardo C Cavalli; Jose E Tanus-Santos
Journal:  Hypertension       Date:  2008-06-23       Impact factor: 10.190

6.  Sodium Nitrite Prevents both Reductions in Circulating Nitric Oxide and Hypertension in 7-Day Lead-Treated Rats.

Authors:  Victor Hugo Gonçalves-Rizzi; Regina Aparecida Nascimento; Jose Sergio Possomato-Vieira; Carlos A Dias-Junior
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-10-01       Impact factor: 4.080

7.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

8.  Increased myeloperoxidase in the placenta and circulation of women with preeclampsia.

Authors:  Robin E Gandley; Jennifer Rohland; Yan Zhou; Eiji Shibata; Gail F Harger; Augustine Rajakumar; Valerian E Kagan; Nina Markovic; Carl A Hubel
Journal:  Hypertension       Date:  2008-06-30       Impact factor: 10.190

9.  Myeloperoxidase, a leukocyte-derived vascular NO oxidase.

Authors:  Jason P Eiserich; Stephan Baldus; Marie-Luise Brennan; Wenxin Ma; Chunxiang Zhang; Albert Tousson; Laura Castro; Aldons J Lusis; William M Nauseef; C Roger White; Bruce A Freeman
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

10.  L-arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsia.

Authors:  Adriana M L Pimentel; Natália R Pereira; Cristiane A Costa; Giovanni E Mann; Viviane S C Cordeiro; Roberto S de Moura; Tatiana M C Brunini; Antônio Cláudio Mendes-Ribeiro; Angela C Resende
Journal:  Hypertens Res       Date:  2013-04-11       Impact factor: 3.872

View more
  1 in total

1.  Resveratrol Protects Cardiac Tissue in Experimental Malignant Hypertension Due to Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Properties.

Authors:  Jelica Grujić-Milanović; Vesna Jaćević; Zoran Miloradović; Djurdjica Jovović; Ivica Milosavljević; Sladjan D Milanović; Nevena Mihailović-Stanojević
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.